Renaissance Technologies’s MetLife MET Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.04M Sell
14,700
-700
-5% -$52.4K ﹤0.01% 2259
2025
Q4
$1.22M Sell
15,400
-429,500
-97% -$34M ﹤0.01% 2173
2025
Q3
$36.6M Buy
444,900
+13,200
+3% +$1.04M 0.05% 453
2025
Q2
$34.7M Buy
431,700
+248,100
+135% +$19.1M 0.05% 470
2025
Q1
$14.7M Buy
+183,600
New +$15.3M 0.02% 808
2024
Q4
Sell
-99,600
Closed -$8.22M 3771
2024
Q3
$8.22M Buy
+99,600
New +$7.44M 0.01% 1146
2023
Q2
Sell
-62,100
Closed -$3.6M 4134
2023
Q1
$3.6M Sell
62,100
-702,000
-92% -$47.4M ﹤0.01% 1671
2022
Q4
$55.3M Buy
+764,100
New +$54.7M 0.08% 305
2022
Q3
Sell
-64,600
Closed -$4.06M 4273
2022
Q2
$4.06M Buy
+64,600
New +$4.28M ﹤0.01% 1712
2019
Q4
Sell
-372,900
Closed -$17.6M 3650
2019
Q3
$17.6M Buy
+372,900
New +$17.8M 0.01% 1036
2017
Q3
Sell
-2,515,360
Closed -$123M 3294
2017
Q2
$123M Buy
2,515,360
+753,259
+43% +$34.9M 0.16% 129
2017
Q1
$83M Buy
+1,762,101
New +$84M 0.12% 203

Other funds holding MET

Renaissance Technologies's MET Position: Q1 2026 in Review

Renaissance Technologies reduced its MetLife (MET) stake by 4.5% in Q1 2026, selling an estimated $52.4K and leaving 14,700 shares worth $1.04M. The position accounts for ﹤0.01% of the portfolio, ranked #2259.

Renaissance Technologies first reported a position in MET in Q1 2017 and has held it in 12 quarters since. The position peaked at $123M in Q2 2017. 1,371 funds tracked by Wall St. Rank hold MET as of Q1 2026.

  • Renaissance Technologies held 14,700 shares of MetLife worth $1.04M as of Q1 2026.
  • Renaissance Technologies sold 700 MetLife shares in Q1 2026, an estimated $52.4K.
  • MetLife made up ﹤0.01% of Renaissance Technologies's portfolio in Q1 2026, its #2259 holding.
  • Renaissance Technologies first reported a position in MetLife in Q1 2017 and has held it in 12 quarters since.
  • Renaissance Technologies's MetLife position peaked at $123M in Q2 2017.
  • 1,371 funds tracked by Wall St. Rank held MetLife as of Q1 2026.

Based on Renaissance Technologies's 13F filing for Q1 2026, filed 14 May 2026.